Compare HCAI & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCAI | CMND |
|---|---|---|
| Founded | 2004 | 2017 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8M | 3.2M |
| IPO Year | 2023 | 2021 |
| Metric | HCAI | CMND |
|---|---|---|
| Price | $2.01 | $6.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 14.1K |
| Earning Date | 09-30-2026 | 09-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $63.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.07 |
| 52 Week High | $25.99 | $7.16 |
| Indicator | HCAI | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 58.04 | 67.16 |
| Support Level | $0.24 | $0.66 |
| Resistance Level | $5.16 | $7.16 |
| Average True Range (ATR) | 0.39 | 0.31 |
| MACD | 0.30 | -0.17 |
| Stochastic Oscillator | 53.46 | 33.33 |
Huachen AI Parking Management Technology Holding Co Ltd a comprehensive electric vehicle charging solutions and equipment structural parts provider. The company has determined that it has only one reported operating segments. It also used to provide customized smart parking solutions to optimize efficiency in limited parking spaces, covering smart cubic parking garage design, cubic parking equipment manufacturing, sales, installation, and maintenance. To cater the customers different parking needs, It manufacture and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.